Honoring our PACT Act of 2022

117-hr-2471 — Consolidated Appropriations Act, 2022

A broad, governmentwide appropriations and policy package that funds agencies across defense, health, housing, science, and foreign aid while adding new program rules, reporting requirements, and oversight across dozens of programs.

117-s-1605 — National Defense Authorization Act for Fiscal Year 2022

Authorizes funding and major policy changes across the U.S. defense and national security enterprise. It sets procurement priorities, R&D and lab authorities, military personnel and family benefits, environmental actions, and many new reporting and pilot requirements. - Service members and families: parental leave is extended to 12 weeks and a new means‑tested Basic Needs Allowance targets those with household income at or below 130% of the federal poverty level. - Procurement and the industrial base: authorizes FY2022 procurement and multiyear buys across the services and adds program limits and reporting rules, including F‑35 affordability controls with Secretary determinations by Oct. 1, 2025. - Research, technology, and environment: expands R&D authorities by codifying the Defense Innovation Unit, creating Science & Technology Reinvention Laboratories, and a National Network for Microelectronics. It also mandates PFAS testing and remediation timelines with preliminary testing due within two years and a 120‑day moratorium on PFAS incineration.

117-hr-4346 — CHIPS and Science Act

This law aims to expand U.S. semiconductor manufacturing and turbocharge federal research, workforce development, and regional technology hubs. It bundles large CHIPS appropriations, a 25% Advanced Manufacturing Investment Credit, and wide DOE/NSF R&D and education authorizations. - Manufacturers and investors: Directs major federal support for domestic chip production, including $24 billion for FY2022 and continuing multi-year CHIPS funding. It also creates a 25% Advanced Manufacturing Investment Credit and new loan and guarantee authority with clawbacks for firms that shift major capacity to countries of concern. - Workers, students, and small businesses: Creates CHIPS workforce and education funds and expands NSF/DOE training and fellowship programs. It authorizes $100 million for scholarships and $125 million for entrepreneurial fellowships and funds small-business vouchers and lab-access vouchers to speed tech translation. - Research institutions and regions: Backs large DOE Office of Science facility upgrades, a $100 million-per-year quantum network R&D program, and nearly $10 billion in Regional Technology and Innovation Hub authorizations to build regional fabrication, testing, and commercialization capacity.

117-hr-1319 — American Rescue Plan Act of 2021

Massive COVID-19 relief funding that combines big public health investments, expanded family support, and large state and local aid to speed vaccinations and stabilize households and services. - Families: The law expands the 2021 Child Tax Credit to $3,600 for children under 6 and $3,000 for children ages 6–17. It also creates refundable advance payments and other tax changes to deliver more cash to families. - Public health and health workers: It funds vaccine distribution, confidence campaigns, and research with $7.5 billion and provides $47.8 billion for testing, tracing, sequencing, lab capacity, and grants to build the public health workforce. - State, local, and housing: It sends large flexible aid with $219.8 billion for states and $130.2 billion for local governments and includes targeted housing help, rental assistance, homeowner aid, and emergency vouchers.

117-hr-5376 — Inflation Reduction Act of 2022

Creates a Medicare price‑negotiation program for high‑priced single‑source drugs. It also remakes taxes and incentives across health, energy, housing, and corporate taxes to lower some health costs and push clean‑energy investment. - Patients and Medicare enrollees see new drug price rules and Part D changes. The bill establishes a Part E Price Negotiation Program with initial lists starting in 2026 (10 drugs in 2026, 15 in 2027 and 2028, 20 in later years) and adds a manufacturer discount program beginning Jan 1, 2025. Insulin deductibles are removed starting 2023 and cost sharing is capped by 2025 at the lesser of $35 or 25% of the negotiated or maximum fair price. - Households get funding to cut home energy costs. The law funds HOMES whole‑house rebates with $4.3 billion and HEHEP point‑of‑sale electrification rebates with $4.275 billion, and low‑income households can receive much larger or even full cost coverage. - Businesses face new tax rules and big clean‑energy incentives. A 15% corporate alternative minimum tax applies to large corporations (generally over $1.0 billion of adjusted financial statement income) and a 1% excise tax applies to stock repurchases. The Act creates or expands many energy credits and allows direct payment or transfer of certain credits for producers and manufacturers.

117-hr-6833 — Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023

Continues federal funding into FY2023. It also provides emergency supplemental aid for Ukraine, creates a FEMA claims program for the Hermit’s Peak/Calf Canyon fires, extends many health and veterans authorities, and reauthorizes FDA user fees through mid‑decade. - Households, disaster survivors, and communities: Funds $1.0 billion for Low Income Home Energy Assistance and transfers $2.5 billion to FEMA for Hermit’s Peak/Calf Canyon claims, while adding crisis services and refugee/entrant assistance. - Veterans and VA users: Extends numerous VA health and benefits authorities, including hospital and nursing home care copayment and service rules through 2024, with other program authorities extended into 2026. - Defense, Ukraine, and oversight: Provides emergency defense and security aid for Ukraine, including $3.0 billion for the Ukraine Security Assistance Initiative and $4.5 billion in direct economic support, and increases reporting, end‑use monitoring, and inspector oversight across transfers and programs.